Skip to main content

Opportunities to Advance the Delivery of High-Quality, Goal-Concordant End-of-Life Care in Ovarian Cancer.

Publication ,  Journal Article
Davidson, BA; Havrilesky, LJ; Lefkowitz, C
Published in: JCO Oncol Pract
March 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JCO Oncol Pract

DOI

EISSN

2688-1535

Publication Date

March 2022

Volume

18

Issue

3

Start / End Page

161 / 163

Location

United States

Related Subject Headings

  • Terminal Care
  • Ovarian Neoplasms
  • Humans
  • Goals
  • Female
  • Advance Care Planning
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Davidson, B. A., Havrilesky, L. J., & Lefkowitz, C. (2022). Opportunities to Advance the Delivery of High-Quality, Goal-Concordant End-of-Life Care in Ovarian Cancer. JCO Oncol Pract, 18(3), 161–163. https://doi.org/10.1200/OP.21.00699
Davidson, Brittany A., Laura J. Havrilesky, and Carolyn Lefkowitz. “Opportunities to Advance the Delivery of High-Quality, Goal-Concordant End-of-Life Care in Ovarian Cancer.JCO Oncol Pract 18, no. 3 (March 2022): 161–63. https://doi.org/10.1200/OP.21.00699.
Davidson BA, Havrilesky LJ, Lefkowitz C. Opportunities to Advance the Delivery of High-Quality, Goal-Concordant End-of-Life Care in Ovarian Cancer. JCO Oncol Pract. 2022 Mar;18(3):161–3.
Davidson, Brittany A., et al. “Opportunities to Advance the Delivery of High-Quality, Goal-Concordant End-of-Life Care in Ovarian Cancer.JCO Oncol Pract, vol. 18, no. 3, Mar. 2022, pp. 161–63. Pubmed, doi:10.1200/OP.21.00699.
Davidson BA, Havrilesky LJ, Lefkowitz C. Opportunities to Advance the Delivery of High-Quality, Goal-Concordant End-of-Life Care in Ovarian Cancer. JCO Oncol Pract. 2022 Mar;18(3):161–163.

Published In

JCO Oncol Pract

DOI

EISSN

2688-1535

Publication Date

March 2022

Volume

18

Issue

3

Start / End Page

161 / 163

Location

United States

Related Subject Headings

  • Terminal Care
  • Ovarian Neoplasms
  • Humans
  • Goals
  • Female
  • Advance Care Planning
  • 3211 Oncology and carcinogenesis